JACOBS LEVY EQUITY MANAGEMENT, INC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$419,472
+393.4%
99,401
+262.4%
0.00%
Q2 2023$85,021
-96.9%
27,426
-98.6%
0.00%
-100.0%
Q1 2023$2,752,820
-18.7%
1,980,446
+16.4%
0.02%
-26.1%
Q4 2022$3,387,050
+16.3%
1,702,035
+18.0%
0.02%0.0%
Q3 2022$2,913,000
-39.9%
1,442,310
-5.4%
0.02%
-39.5%
Q2 2022$4,847,000
-26.8%
1,524,176
-4.0%
0.04%
-15.6%
Q1 2022$6,622,000
-18.7%
1,587,956
-6.6%
0.04%
-18.2%
Q4 2021$8,148,000
-18.9%
1,701,057
-9.6%
0.06%
-19.1%
Q3 2021$10,051,000
-6.5%
1,882,186
-10.4%
0.07%
-6.8%
Q2 2021$10,752,000
-3.9%
2,099,934
+26.3%
0.07%
-15.1%
Q1 2021$11,192,000
+242.6%
1,663,052
+132.7%
0.09%
+196.6%
Q4 2020$3,267,000
+180.4%
714,819
+138.1%
0.03%
+141.7%
Q3 2020$1,165,000
+249.8%
300,273
+328.7%
0.01%
+200.0%
Q2 2020$333,000
-61.4%
70,049
-71.7%
0.00%
-63.6%
Q1 2020$862,000
+48.1%
247,774
+23.5%
0.01%
+57.1%
Q3 2019$582,000
+132.8%
200,600
+476.4%
0.01%
+133.3%
Q2 2019$250,00034,8000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders